Patient-identified early clinical warning signs of nodular melanoma: a qualitative study

[1] Little EG(2012)Update on the current state of melanoma incidence Dermatol Clin 30 355-361

[2] Eide MJ(2016)State of the science on prevention and screening to reduce melanoma incidence and mortality: the time is now CA Cancer J Clin 66 460-480

[3] Tripp MK(2019)Melanoma incidence among non-hispanic whites in all 50 US States from 2001 through 2015 J Natl Cancer Inst 112 533-539

[4] Watson M(2012)Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model Melanoma Res 22 1-8

[5] Balk SJ(2006)The relationship between melanoma thickness and time to diagnosis in a large population-based study Arch Dermatol 142 1422-1427

[6] Swetter SM(2013)Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia J Am Acad Dermatol 68 568-575

[7] Gershenwald JE(2012)Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia J Clin Oncol 30 1462-1467

[8] Thrift AP(2012)Behavioral determinants of successful early melanoma detection: role of self and physician skin examination Cancer 118 3725-3734

[9] Gudenkauf FJ(2016)An assessment of clinical pathways and missed opportunities for the diagnosis of nodular melanoma versus superficial spreading melanoma: pathways for diagnosis of NM versus SSM Austr J Dermatol 57 97-101

[10] Greenwald HS(2014)Individual and ecological factors associated with early detection of nodular melanoma in the United States Melanoma Res 24 165-171

[1] Little EG(2012)Update on the current state of melanoma incidence Dermatol Clin 30 355-361

[2] Eide MJ(2016)State of the science on prevention and screening to reduce melanoma incidence and mortality: the time is now CA Cancer J Clin 66 460-480

[3] Tripp MK(2019)Melanoma incidence among non-hispanic whites in all 50 US States from 2001 through 2015 J Natl Cancer Inst 112 533-539

[4] Watson M(2012)Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model Melanoma Res 22 1-8

[5] Balk SJ(2006)The relationship between melanoma thickness and time to diagnosis in a large population-based study Arch Dermatol 142 1422-1427

[6] Swetter SM(2013)Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia J Am Acad Dermatol 68 568-575

[7] Gershenwald JE(2012)Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia J Clin Oncol 30 1462-1467

[8] Thrift AP(2012)Behavioral determinants of successful early melanoma detection: role of self and physician skin examination Cancer 118 3725-3734

[9] Gudenkauf FJ(2016)An assessment of clinical pathways and missed opportunities for the diagnosis of nodular melanoma versus superficial spreading melanoma: pathways for diagnosis of NM versus SSM Austr J Dermatol 57 97-101

[10] Greenwald HS(2014)Individual and ecological factors associated with early detection of nodular melanoma in the United States Melanoma Res 24 165-171